Avenue Therapeutics, Inc.

... ...
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Pharmaceuticals Major
JNJJohnson & Johnson -1.40%168.090.7%$1402.63m
PFEPfizer Inc. -2.81%36.260.9%$1195.23m
LLYEli Lilly & Co. -2.32%207.781.1%$1074.78m
ABBVAbbVie, Inc. -5.63%102.671.9%$741.72m
MRKMerck & Co., Inc. -3.94%77.090.7%$708.42m
BMYBristol-Myers Squibb Co. -3.76%62.021.0%$696.22m
AZNAstraZeneca Plc -4.30%52.101.2%$673.47m
ARCTArcturus Therapeutics Holdings, Inc. 3.40%67.200.0%$223.89m
NVSNovartis AG -3.17%92.900.2%$203.33m
VTRSViatris, Inc. -1.35%16.860.0%$197.28m
RPRXRoyalty Pharma Plc -4.75%50.310.2%$174.96m
GSKGlaxoSmithKline Plc -2.70%38.180.2%$162.18m
SNYSanofi -3.70%47.330.2%$135.17m
GRTSGritstone Oncology, Inc. -15.86%17.300.0%$134.87m
TAKTakeda Pharmaceutical Co., Ltd. -3.47%17.550.0%$84.27m

Company Profile

Avenue Therapeutics, Inc. engages in acquiring, licensing, developing, and commercializing products for use in the intensive care hospital setting. It focuses on the development of intravenous tramadol, which is intended for the treatment of moderate to moderately severe post-operative pain. The company was founded on February 9, 2015 and is headquartered in New York, NY.